Related Experiment Video
Updated: Jan 9, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Optimizing the "right" patient selection for treatment for sickle cell disease
Raffaella Colombatti1,2, Giulia Reggiani1,2
1Department of Women's and Child's Health, University of Padova, Padova, Italy.
Selecting the right treatment for sickle cell disease (SCD) requires a personalized approach. Factors like disease severity, patient preferences, and access to care are crucial for effective SCD management and improved outcomes.
Area of Science:
- Hematology
- Genetics
- Public Health
Background:
- Sickle cell disease (SCD) is a global hemoglobinopathy with diverse clinical presentations.
- The expanding therapeutic options for SCD necessitate refined patient selection criteria.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Multiple Allele Traits
Kidney Transplant I: Introduction
Bioavailability Study Design: Healthy Subjects Versus Patients